HIF1A and bile duct cancer: Previously, we demonstrated that PDT of human skin and bile duct cancer cells with liposomal ZnPC and acriflavine, an inhibitor of hypoxia-inducible factor 1α (HIF-1α) [15], increases therapeutic efficacy by downmodulation of HIF-1α-driven survival signaling following PDT [11, 13].